Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality.

MLA

Mirza, M.Ayoub, et al. “Phospholemman Deficiency in Postinfarct Hearts: Enhanced Contractility but Increased Mortality.” Clinical and Translational Science, vol. 5, no. 3, June 2012, pp. 235–42. EBSCOhost, https://doi.org/10.1111/j.1752-8062.2012.00403.x.

APA

Mirza, M. A., Lane, S., Yang, Z., Karaoli, T., Akosah, K., Hossack, J., McDuffie, M., Wang, J., Zhang, X.-Q., Song, J., Cheung, J. Y., & Tucker, A. L. (2012). Phospholemman deficiency in postinfarct hearts: enhanced contractility but increased mortality. Clinical and Translational Science, 5(3), 235–242. https://doi.org/10.1111/j.1752-8062.2012.00403.x

Chicago

Mirza, M Ayoub, Susan Lane, Zequan Yang, Themis Karaoli, Kwame Akosah, John Hossack, Marcia McDuffie, et al. 2012. “Phospholemman Deficiency in Postinfarct Hearts: Enhanced Contractility but Increased Mortality.” Clinical and Translational Science 5 (3): 235–42. doi:10.1111/j.1752-8062.2012.00403.x.